Actively Recruiting
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
Led by University Hospital, Geneva · Updated on 2026-05-12
163
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study is to evaluate whether hormonal medications (such as contraceptive pill, patch, injectable progestins and hormonal intra-uterine device) have similar efficacy at managing heavy menstrual bleeding in adolescents with a bleeding disorder compared to those without. We also aim to assess the quality of life and hemoglobin and iron levels in this population.
CONDITIONS
Official Title
Hormonal Management of Heavy Menstrual Bleeding in Adolescents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adolescents and young adults aged less than 26 years
- Presenting to the gynecology consultation at HUG
- Diagnosed with heavy menstrual bleeding (PBAC > 100)
- Willing to initiate a hormonal medication to manage heavy menstrual bleeding
You will not qualify if you...
- Pregnancy or planning to become pregnant during the study period
- Already using hormonal medication for menstrual management and/or contraception
- Known anatomical uterine pathology
- Using anticoagulant or antiaggregant agents
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Geneva University Hospitals
Geneva, Switzerland, 1205
Actively Recruiting
Research Team
D
Dehlia Moussaoui, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here